Analysis Tools|
Allele Symbol Allele Name Allele ID |
Mtortm1.2Seq targeted mutation 1.2, Susan E Quaggin MGI:5425404 |
||||||||||||
| Summary |
2 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• growth restriction observed starting around 4 weeks of age
• no overt phenotypes until after 3 weeks of age
|
|
• protein/creatinine ratio is significantly increased at 3 weeks of age
|
|
• protein/creatinine ratio is significantly increased at 3 weeks of age
|
|
• distended Bowman's space at 5 weeks
|
|
• numerous vacuolated podocytes at 4 weeks of age
• widespread vacuolation of podocytes at 5 weeks of age
|
|
• focal effacement at 3 weeks of age but endothelium and glomerular basement membranes are preserved
|
|
• areas of sclerosis at 4 weeks of age
• complete destruction of glomerular tuft at 5 weeks of age
|
|
• proteinaceous casts found in tubules of 2-3 week old mice
|
|
• autophagosomal vesicles accumulate in podocytes beginning at 2 weeks of age
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||


